Search

Displaying results 9371 - 9380 of 10000 in total
  1. Drug

    IR502

    go.drugbank.com/drugs/DB06463
    Experimental

    IR502 (Zorcell) is a potential treatment for psoriasis.

  2. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental

  3. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  4. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  5. Drug

    Nemonoxacin

    go.drugbank.com/drugs/DB06600
    Investigational

  6. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  7. Drug

    Priralfinamide

    go.drugbank.com/drugs/DB06649
    Investigational

  8. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  9. Drug

    Amediplase

    go.drugbank.com/drugs/DB06679
    Experimental

    Amediplase is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain from the A-chain of tissue plasminogen activator (t-PA) and the carboxy terminal region of pro-urokinase. [MeSH]

  10. Drug

    Orbifloxacin

    go.drugbank.com/drugs/DB11443
    ExperimentalVet approved

    It is marketed by Schering-Plough Animal Health and approved for certain infections in dogs.